GSK, Sanford Burnham Prebys Create Translational Neuroscience Center

Sanford Burnham Prebys Medical Discovery Institute (SBP) and GlaxoSmithKline (GSK) said today they have created a new center designed to advance translational neuroscience by identifying and validating new therapeutic targets. The new SBP-GSK Center for Translational Neuroscience—to be located on SBP’s campus in La Jolla, CA—will promote collaboration by researchers from SBP and GSK. SBP scientists, postdoctoral candidates, and technicians will work with neuroscientists from GSK to investigate factors that influence brain function and potentially reverse or slow down neurodegeneration, the research institute said. GSK will provide an undisclosed amount of funding to create and support the new Center for 3 years, SBP added. The collaboration is intended to combine the expertise of SBP scientists in basic neuroscience research with GSK’s pharmaceutical development capability and know-how. “This unique alliance provides…


Link to Full Article: GSK, Sanford Burnham Prebys Create Translational Neuroscience Center